Ralitsa Madsen
Company: University College London
Job title: Research Fellow
Seminars:
Live Q&A – Ask the Speakers Your Burning Questions 12:20 pm
day: Day One
New Insights into PI3K Dose Control and its Therapeutic Implications 11:20 am
The development of reliable, prognostically informative molecular tests to direct targeted cancer therapy is a major challenge Our data (1) corroborate reports that the presence of a PIK3CA mutation per se does not predict high PI3K pathway activation or poor prognosis; (2) suggest that stratification of breast cancer for PI3K-based therapy might benefit from being…Read more
day: Day One